Multidrug-Resistant <i>Mycobacterium tuberculosis</i> in a Community Hospital, Luanda, Angola
In a longitudinal study in a first-level hospital in Luanda, Angola, we found rifampin-resistant and multidrug-resistant tuberculosis (TB) in 38 (8%, 95% CI 5.7-10.8) of 474 patients with no previous history of TB. Of note, 2 patients (0.4%, 95% CI 0.1-1.5) demonstrated pre-extensively drug-resistant TB.
Authors
- Alberto Matteelli (ORCID: https://orcid.org/0000-0001-5109-9248)
- Dora Buonfrate (ORCID: https://orcid.org/0000-0003-0108-6822)
- Francesca Alladio (ORCID: https://orcid.org/0009-0004-5640-8803)
- Concetta Castilletti (ORCID: https://orcid.org/0000-0001-9819-236X)
- Federico Giovanni Gobbi (ORCID: https://orcid.org/0000-0002-6899-4545)
- A Kalume
- Alberto Gaviraghi (ORCID: https://orcid.org/0009-0009-3860-9130)
- Ralph Huits (ORCID: https://orcid.org/0000-0001-8803-9468)
- Ngiambudulu M. Francisco (ORCID: https://orcid.org/0000-0003-3255-8968)
- Elena Salvador (ORCID: https://orcid.org/0009-0005-5561-1268)
- Giacomo Stroffolini (ORCID: https://orcid.org/0000-0001-8012-0237)
- Cristina Mazzi (ORCID: https://orcid.org/0000-0002-4561-3447)
- Niccolò Ronzoni (ORCID: https://orcid.org/0000-0003-2966-5973)
- Paolo Cattaneo (ORCID: https://orcid.org/0000-0002-2016-3224)
- Bruna Carnielli
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-02-21
- DOI
- https://doi.org/10.3201/eid3103.241831
- Citations
- 3
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- GlaxoSmithKline
- Ministero della Salute
- Inamori Foundation
- Senri Life Science Foundation
- Japanese Respiratory Society
- Japan Society for the Promotion of Science